e1 References 1 Najafi A, Sequeira V, Kuster DWD, et al b adrenergic receptor signalling and its functional consequences in the diseased heart Eur J Clin Invest 2016;46(4) 362 374 2 O’Connell TD, Jens[.]
e1 References Najafi A, Sequeira V, Kuster DWD, et al b-adrenergic receptor signalling and its functional consequences in the diseased heart Eur J Clin Invest 2016;46(4):362-374 O’Connell TD, Jensen BC, Baker AJ, et al Cardiac Alpha 1-adrenergic receptors: novel aspects of expression, signaling mechanisms, physiologic function, and clinical importance Pharmacol Rev 2014; 308-333 Alberts B Molecular Biology of the Cell New York: Garland Publishing; 1994 Kamp TJ, Hell JW Regulation of cardiac L-type calcium channels by protein kinase A and protein kinase C Circ Res 2000;87(12):1095-1102 Guimarães S, Moura D Vascular adrenoceptors: an update Pharmacol Rev 2001;53(2):319-356 Piascik MT, Perez DM Alpha1-adrenergic receptors: new insights and directions J Pharmacol Exp Ther 2001;298(2):403-410 Graham R Alpha1-adrenergic receptors In: D Robertson, editor Primer on the Autonomic Nervous System, 2nd ed Boston: Elsevier; 2004;50-53 Park MK Use of digoxin in infants and children, with specific emphasis on dosage J Pediatr 1986;108(6):871-877 Michelotti GA, Price DT, Schwinn DA Alpha 1-adrenergic receptor regulation: basic science and clinical implications Pharmacol Ther 2000;88(3):281-309 10 Jensen BC, O’Connell TD, Simpson PC Alpha-1–Adrenergic Receptors in Heart Failure J Cardiovasc Pharmacol 2014;63(4):291-301 11 Somlyo AP, Somlyo AV Signal transduction and regulation in smooth muscle Nature 1994;372(6503):231-236 12 Andersen G, Qvigstad E, Schiander I, et al Alpha(1)-AR-induced positive inotropic response in heart is dependent on myosin light chain phosphorylation Am J Physiol Heart Circ Physiol 2002;283(4):H1471-H1480 13 Minneman KP Alpha 1-adrenergic receptor subtypes, inositol phosphates, and sources of cell Ca21 Pharmacol Rev 1988;40(2):87-119 14 Smiley RM, Kwatra MM, Schwinn D New developments in cardiovascular adrenergic receptor pharmacology: molecular mechanisms and clinical relevance J Cardiothorac Vasc Anesth 1998;12(1):80-95 15 Leone M, Albanèse J, Martin C Positive inotropic stimulation Curr Opin Crit Care 2002;8(5):395-403 16 Garcia-Sainz JA, Vazquez-Prado J, del Carmen Medina L Alpha 1-adrenoceptors: function and phosphorylation Eur J Pharmacol 2000;389:1-12 17 Singh M, Notterman DA, Metakis L Tumor necrosis factor produces homologous desensitization of lymphocyte beta 2-adrenergic responses Circ Shock 1993;39(4):275-278 18 Rochais F, Vilardaga JP, Nikolaev VO, et al Real-time optical recording of b1-adrenergic receptor activation reveals supersensitivity of the Arg389 variant to carvedilol J Clin Invest 2007;117(1):229-235 19 Holmes CL, Patel BM, Russell JA, et al Physiology of vasopressin relevant to management of septic shock Chest 120(3):989-1002 20 Jackson EK Vasopressin and other agents affecting the renal conservation of water In: Hardman JG, Limbird LE, Molinoff B, et al., eds Goodman and Gillman’s The Pharmacological Basis of Therapeutics New York: McGraw-Hill; 1996:715-732 21 Hasser EM, Bishop VS, Hay M Interactions between vasopressin and baroreflex control of the sympathetic nervous system Clin Exp Pharmacol Physiol 1997;24(1):102-108 22 Luk J, Ajaelo I, Wong V, et al Role of V1 receptors in the action of vasopressin on the baroreflex control of heart rate Am J Physiol 1993;265(3 Pt 2):R524-R529 23 Undesser KP, Hasser EM, Haywood JR, et al Interactions of vasopressin with the area postrema in arterial baroreflex function in conscious rabbits Circ Res 1985;56(3):410-417 24 Holmes Physiology of vasopressin relevant to mgmnt of septic shock Chest 2001;120(3):989 25 Nemenoff RA Vasopressin signaling pathways in vascular smooth muscle Front Biosci 1998;3:d194-d207 26 Choong K Vasopressin in pediatric critical care J Pediatr Intensive Care 2016;5(4):182-188 27 Webb JG, Yates PW, Yang Q, et al Adenylyl cyclase isoforms and signal integration in models of vascular smooth muscle cells Am J Physiol Heart Circ Physiol 2001;281(4):H1545-H1552 28 Chandrashekhar Y, Prahash AJ, Sen S, et al The role of arginine vasopressin and its receptors in the normal and failing rat heart J Mol Cell Cardiol 2003;35(5):495-504 29 Birnbaumer M Vasopressin receptors Trends Endocrinol Metab 2000;11(10):406-410 30 Dousa TP Cyclic-3’,5’-nucleotide phosphodiesterase isozymes in cell biology and pathophysiology of the kidney Kidney Int 1999;55(1): 29-62 31 Movsesian MA PDE3 cyclic nucleotide phosphodiesterases and the compartmentation of cyclic nucleotide-mediated signalling in cardiac myocytes Basic Res Cardiol 2002;97(suppl 1):I83-I90 32 Farah AE, Frangakis CJ Studies on the mechanism of action of the bipyridine milrinone on the heart Basic Res Cardiol 1989;84(1):85-103 33 Schlepper M, Thormann J, Kremer P, et al Present use of positive inotropic drugs in heart failure J Cardiovasc Pharmacol 1989; 14(suppl 1):S9-S19 34 Shipley JB, Tolman D, Hastillo A, et al Milrinone: basic and clinical pharmacology and acute and chronic management Am J Med Sci 1996;311(6):286-291 35 Chatterjee K Newer oral inotropic agents: phosphodiesterase inhibitors Crit Care Med 1990;18(1 Pt 2):S34-S38 36 Yano M, Kohno M, Ohkusa T, et al Effect of milrinone on left ventricular relaxation and Ca(21) uptake function of cardiac sarcoplasmic reticulum Am J Physiol Heart Circ Physiol 2000;279(4): H1898-H1905 37 Skoyles JR, Sherry KM Pharmacology, mechanisms of action and uses of selective phosphodiesterase inhibitors Br J Anaesth 1992; 68(3):293-302 38 Schwinger RH, Bundgaard H, Muller-Ehmsen J, et al The ATPase in the failing human heart Cardiovasc Res 2003;57:913 39 Fambrough DM, Lemas MV, Hamrick M, et al Analysis of subunit assembly of the Na-K-ATPase Am J Physiol 1994;266(3 Pt 1): C579-C589 40 Wang J, Schwinger RH, Frank K, et al Regional expression of sodium pump subunits isoforms and Na1-Ca11 exchanger in the human heart J Clin Invest 1996;98(7):1650-1658 41 Artman M, Henry G, Coetzee WA Cellular basis for age-related differences in cardiac excitation–contraction coupling Prog Pediatr Cardiol 2000;11(3):185-194 42 Shigekawa M, Iwamoto T Cardiac Na(1)-Ca(21) exchange: molecular and pharmacological aspects Circ Res 2001;88(9):864-876 43 Schmidt TA, Allen PD, Colucci WS, et al No adaptation to digitalization as evaluated by digitalis receptor (Na,K-ATPase) quantification in explanted hearts from donors without heart disease and from digitalized recipients with end-stage heart failure Am J Cardiol 1993; 71(1):110-114 44 Bohn DJ, Poirier CS, Edmonds JF, et al Hemodynamic effects of dobutamine after cardiopulmonary bypass in children Crit Care Med 1980;8(7):367-371 45 Akita T, Joyner RW, Lu C, et al Developmental changes in modulation of calcium currents of rabbit ventricular cells by phosphodiesterase inhibitors Circulation 1994;90(1):469-478 46 Friedman WF, George BL New concepts and drugs in the treatment of congestive heart failure Pediatr Clin North Am 1984;31(6): 1197-1227 47 Swedlow DB, Raphaely RC, eds Cardiovascular Problems in Pediatric Critical Care New York: Churchill Livingstone; 1986 48 Mielgo V, Valls i Soler A, Rey-Santano C Dobutamine in paediatric population: a systematic review in juvenile animal models PLoS One 2014;9(4):e95644 49 Hoffman BB, Taylor P, Hardman JG, et al Neurotransmission In: Goodman and Gilman’s the Pharmacologic Basis of Therapeutics New York: McGraw Hill; 1996 e2 50 Kopin IJ Catecholamine metabolism: basic aspects and clinical significance Pharmacol Rev 1985;37:333-364 51 Moran JL, O’Fathartaigh MS, Peisach AR, et al Epinephrine as an inotropic agent in septic shock: a dose-profile analysis Crit Care Med 1993;21(1):70-77 52 Steel A, Bihari D Choice of catecholamine: does it matter? Curr Opin Crit Care 2000;6:5 53 Smolich JJ, Cox HS, Esler MD Contribution of lungs to desipramine-induced changes in whole body catecholamine kinetics in newborn lambs Am J Physiol 1999;276(1 Pt 2):R243-R250 54 Friedgen B, Wölfel R, Graefe KH The contribution by monoamine oxidase and catechol-O-methyltransferase to the total-body and pulmonary plasma clearance of catecholamines Naunyn Schmiedebergs Arch Pharmacol 1996;353(2):193-199 55 Li YH, Wirth T, Huotari M, et al No change of brain extracellular catecholamine levels after acute catechol-O-methyltransferase inhibition: a microdialysis study in anaesthetized rats Eur J Pharmacol 1998;356(2-3):127-137 56 Allen E, Pettigrew A, Frank D, et al Alterations in dopamine clearance and catechol-O-methyltransferase activity by dopamine infusions in children Crit Care Med 25(1):181-189 57 Chu CA, Sindelar DK, Neal DW, et al Hepatic and gut clearance of catecholamines in the conscious dog Metabolism 1999;48(2):259-263 58 Eisenhofer G, Rundquist B, Aneman A, et al Regional release and removal of catecholamines and extraneuronal metabolism to metanephrines J Clin Endocrinol Metab 1995;80(10):3009-3017 59 Notterman DA, Greenwald BM, Moran F, et al Dopamine clearance in critically ill infants and children: effect of age and organ system dysfunction Clin Pharmacol Ther 1990;48(2):138-147 60 Goldberg LI, Rajfer SI Dopamine receptors: applications in clinical cardiology Circulation 1985;72(2):245-248 61 Van den Berghe G, de Zegher F, Lauwers P Dopamine suppresses pituitary function in infants and children Crit Care Med 1994;22(11):1747-1753 62 Chernow B, ed Essentials of Critical Care Pharmacology Baltimore: Williams & Wilkins; 1994 63 Beregovich J, Bianchi C, Rubler S, et al Dose-related hemodynamic and renal effects of dopamine in congestive heart failure Am Heart J 1974;87(5):550-557 64 Goldberg LI Dopamine—clinical uses of an endogenous catecholamine N Engl J Med 1974;291(14):707-710 65 Matayoshi Y, Sari A, Nagai K, et al Hemodynamic effects of dopamine in critically ill patients (author’s transl) Masui 1979;28(8): 791-796 66 Gundert-Remy U, Penzien J, Hildebrandt R, et al Correlation between the pharmacokinetics and pharmacodynamics of dopamine in healthy subjects Eur J Clin Pharmacol 1984;26(2):163-169 67 Seri I, Abbasi S, Wood DC, et al Regional hemodynamic effects of dopamine in the sick preterm neonate J Pediatr 1998;133(6):728-734 68 Subhedar NV, Shaw NJ Dopamine versus dobutamine for hypotensive preterm infants Cochrane Database Syst Rev 2003;(3):CD001242 69 Gupta S, Donn SM Neonatal hypotension: dopamine or dobutamine? Semin Fetal Neonatal Med 2014;19(1):54-59 70 Barrington KJ Circulatory effects of dopamine in neonates J Pediatr 1995;127(5):843-844 71 Perez CA, Reimer JM, Schreiber MD, et al Effect of high-dose dopamine on urine output in newborn infants Crit Care Med 1986; 14(12):1045-1049 72 Padbury JF, Agata Y, Baylen BG, et al Dopamine pharmacokinetics in critically ill newborn infants J Pediatr 1987;110(2):293-298 73 Seri I, Abbasi S, Wood DC, et al Regional hemodynamic effects of dopamine in the sick preterm neonate J Pediatr 1998;133(6): 728-734 74 Wong FY, Barfield CP, Horne RSC, et al Dopamine therapy promotes cerebral flow-metabolism coupling in preterm infants Intensive Care Med 2009;35(10):1777-1782 75 Juste RN, Moran L, Hooper J, et al Dopamine clearance in critically ill patients Intensive Care Med 1998;24(11):1217-1220 76 MacLeod CM Drugs used in the acutely ill patient Dis Mon 1993;39(6):362-501 77 McEvoy GK, ed Dopamine hydrochloride In: AHFS Drug Information Bethesda, MD: American Society of Health-System Pharmacists; 2009 78 Eldadah MK, Schwartz PH, Harrison R, et al Pharmacokinetics of dopamine in infants and children Crit Care Med 1991;19(8):1008-1011 79 Berg RA, Padbury JF, Donnerstein RL, et al Dobutamine pharmacokinetics and pharmacodynamics in normal children and adolescents J Pharmacol Exp Ther 1993;265(3):1232-1238 80 MacGregor DA, Smith TE, Prielipp RC, et al Pharmacokinetics of dopamine in healthy male subjects Anesthesiology 2000;92(2):338-346 81 Allen E, Pettigrew A, Frank D, et al Alterations in dopamine clearance and catechol-O-methyltransferase activity by dopamine infusions in children Crit Care Med 1997;25(1):181-189 82 Berg RA, Padbury JF, Donnerstein RL, et al Dobutamine pharmacokinetics and pharmacodynamics in normal children and adolescents J Pharmacol Exp Ther 1993;265(3):1232-1238 83 Kapiloff MS Contributions of protein kinase A anchoring proteins to compartmentation of cAMP signaling in the heart Mol Pharmacol 2002;62(2):193-199 84 Vernon DD, Dean JM, Banner W, et al Nonlinear dopamine pharmacokinetics in pediatric patients J Pharmacol Exp Ther 1989;249:131 85 Yan M, Webster LT, Blumer JL Kinetic interactions of dopamine and dobutamine with human catechol-O-methyltransferase and monoamine oxidase in vitro J Pharmacol Exp Ther 2002;301(1):315-321 86 Carcillo JA, Fields AI, American College of Critical Care Medicine Task Force Committee Members Clinical practice parameters for hemodynamic support of pediatric and neonatal patients in septic shock Crit Care Med 2002;30(6):1365-1378 87 Sharma VK, Dellinger RP The International Sepsis Forum’s controversies in sepsis: my initial vasopressor agent in septic shock is norepinephrine rather than dopamine Crit Care 2003;7(1):3-5 88 Vincent JL, de Backer D The International Sepsis Forum’s controversies in sepsis: my initial vasopressor agent in septic shock is dopamine rather than norepinephrine Crit Care 2003;7(1):6-8 89 Dellinger RP, Levy MM, Rhodes A, et al Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012 Crit Care Med 2013;41(2):580-637 90 Rhodes A, Evans LE Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 Crit Care Med 2017;45(3):486-552 91 Kawasaki T Update on pediatric sepsis: a review J Intensive Care 2017;5:47 92 Ramaswamy KN, Singhi S, Jayashree M, et al Double-blind randomized clinical trial comparing dopamine and epinephrine in pediatric fluid-refractory hypotensive septic shock Pediatr Crit Care Med 2016;17(11):e502-e512 93 2005 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care Part 7.4: monitoring and medications Circulation 2005;112(suppl24):IV78-IV83 94 ECC Committee, Subcommittee, and Task Forces of the American Heart Association 2005 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care Circulation 2005;112:IV1-IV203 95 Morales-Demori R, Anders M 278: The use of inotropic and vasoconstrictor medications in the pediatric heart failure population Crit Care Med 2019;47(Supp 1):120 96 Hoffman BB, Lefkowitz RJ Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists In: Hardman JG, Limbird LE, Molinoff PB, et al., eds Goodman and Gillman’s The Pharmacological Basis of Therapeutics Baltimore: McGraw Hill; 1996;199-242 97 Balakumaran K, Hugenholtz PG Cardiogenic shock Current concepts in Management Drugs 1986;32(4):372-382 98 Lemaire F Effect of catecholamines on pulmonary right-to-left shunt Int Anesthesiol Clin 1983;21(2):43-58 99 Rennotte MT, Reynaert M, Clerbaux T, et al Effects of two inotropic drugs, dopamine and dobutamine, on pulmonary gas exchange e3 in artificially ventilated patients Intensive Care Med 1989;15(3): 160-165 100 Levin ER, Gardner DG, Samson WK Natriuretic peptides N Engl J Med 339(5):321-328 101 Day NP, Phu NH, Bethell DP, et al The effects of dopamine and adrenaline infusions on acid-base balance and systemic haemodynamics in severe infection Lancet 348(9022):219-223 102 Lisbon A Dopexamine, dobutamine, and dopamine increase splanchnic blood flow: What is the evidence? Chest 2003;123(suppl 5): 460S-463S 103 Silva E, DeBacker D, Créteur J, et al Effects of vasoactive drugs on gastric intramucosal pH Crit Care Med 1998;26(10):1749-1758 104 Thorén A, Elam M, Ricksten SE Differential effects of dopamine, dopexamine, and dobutamine on jejunal mucosal perfusion early after cardiac surgery Crit Care Med 2000;28(7):2338-2343 105 Hannemann L, Reinhart K, Grenzer O, et al Comparison of dopamine to dobutamine and norepinephrine for oxygen delivery and uptake in septic shock Crit Care Med 1995;23(12):1962-1970 106 Jakob SM, Ruokonen E, Takala J Effects of dopamine on systemic and regional blood flow and metabolism in septic and cardiac surgery patients Shock 2002;18(1):8-13 107 Oberbeck R, Schmitz D, Wilsenack K, et al Dopamine affects cellular immune functions during polymicrobial sepsis Intensive Care Med 2006;32(5):731-739 108 Van den Berghe G, de Zegher F, Lauwers P Dopamine suppresses pituitary function in infants and children Pediatr Nephrol 1995; 9(4):482 109 Notterman DA Inotropic agents Catecholamines, digoxin, amrinone Crit Care Clin 1991;7(3):583-613 110 Siwy BK, Sadove AM Acute management of dopamine infiltration injury with Regitine Plast Reconstr Surg 1987;80(4):610-612 111 Cornell University Integrated Dosing Calculator for Emergency Medications & Medicated Infusion Tables 2013 Available at: http:// www-users.med.cornell.edu/,spon/picu/calc/druginp5.htm 112 Orlowski JP, Porembka DT, Gallagher JM, et al Comparison study of intraosseous, central intravenous, and peripheral intravenous infusions of emergency drugs Am J Dis Child 1990;144(1):112-117 113 Trissel LA, Gilbert DL, Martinez JF, et al Compatibility of medications with 3-in-1 parenteral nutrition admixtures JPEN J Parenter Enteral Nutr 1999;23(2):67-74 114 Peddicord TE, Olsen KM, Zumbrunnen TL, et al Stability of high-concentration dopamine hydrochloride, norepinephrine bitartrate, epinephrine hydrochloride, and nitroglycerin in 5% dextrose injection Am J Health Syst Pharm 1997;54(12):1417-1419 115 Ghanayem NS, Yee L, Nelson T, et al Stability of dopamine and epinephrine solutions up to 84 hours Pediatr Crit Care Med 2001;2(4):315-317 116 Hoffman BB, Taylor P, Hardman JG, et al Neurotransmission In: Goodman and Gilman’s the Pharmacologic Basis of Therapeutics, New York: McGraw Hill; 2001 Vol 2001 SRC 117 Sun D, Huang A, Mital S, et al Norepinephrine elicits beta2receptor-mediated dilation of isolated human coronary arterioles Circulation 2002;106(5):550-555 118 Borthne K, Hågå P, Langslet a, et al Endogenous norepinephrine stimulates both alpha 1- and beta-adrenoceptors in myocardium from children with congenital heart defects J Mol Cell Cardiol 1995;27(1):693-699 119 Skomedal T, Borthne K, Aass H, et al Comparison between alpha-1 adrenoceptor-mediated and beta adrenoceptor-mediated inotropic components elicited by norepinephrine in failing human ventricular muscle J Pharmacol Exp Ther 1997;280(2):721-729 120 Desjars P, Pinaud M, Potel G, et al A reappraisal of norepinephrine therapy in human septic shock Crit Care Med 1987;15(2):134-137 121 Tourneux P, Rakza T, Bouissou A, et al Pulmonary circulatory effects of norepinephrine in newborn infants with persistent pulmonary hypertension J Pediatr 2008;153(3):345-349 122 Tourneux P, Rakza T, Abazine A, et al Noradrenaline for management of septic shock refractory to fluid loading and dopamine or dobutamine in full-term newborn infants Acta Paediatr 2008; 97(2):177-180 123 Cryer PE Physiology and pathophysiology of the human sympathoadrenal neuroendocrine system N Engl J Med 1980;303(8):436-444 124 Beloeil H, Mazoit J-X, Benhamou D, et al Norepinephrine kinetics and dynamics in septic shock and trauma patients Br J Anaesth 2005;95(6):782-788 125 Goldstein DS, Eisenhofer G, Kopin IJ Sources and significance of plasma levels of catechols and their metabolites in humans J Pharmacol Exp Ther 2003;305(3):800-811 126 Desjars P, Pinaud M, Bugnon D, et al Norepinephrine therapy has no deleterious renal effects in human septic shock Crit Care Med 1989;17(5):426-429 127 Fukuoka T, Nishimura M, Imanaka H, et al Effects of norepinephrine on renal function in septic patients with normal and elevated serum lactate levels Crit Care Med 1989;17(11):1104-1107 128 Hesselvik JF, Brodin B Low dose norepinephrine in patients with septic shock and oliguria: effects on afterload, urine flow, and oxygen transport Crit Care Med 1989;17(2):179-180 129 View CA Natrecor (nesiritide) [USP package insert] Mountain: Scios Inc; 2007 130 Brierley J, Carcillo JA, Choong K, et al Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine Crit Care Med 2009;37(2):666-688 131 Dellinger RP, Levy MM, Rhodes A, et al Surviving Sepsis Campaign Crit Care Med 2013;41(2):580-637 132 Davis AL, Carcillo JA, Aneja RK, et al The American College of Critical Care Medicine clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: executive summary Pediatr Crit Care Med 2017;18(9):884-890 133 Martin C, Viviand X, Leone M, et al Effect of norepinephrine on the outcome of septic shock Crit Care Med 2000;28(8):2758-2765 134 Di Giantomasso D, May CN, Bellomo R Norepinephrine and vital organ blood flow during experimental hyperdynamic sepsis Intensive Care Med 2003;29(10):1774-1781 135 Lampin ME, Rousseaux J, Botte A, et al Noradrenaline use for septic shock in children: Doses, routes of administration and complications Acta Paediatr 2012;101(9):e426-e430 136 Martin C, Viviand X, Leone M, et al Effect of norepinephrine on the outcome of septic shock Crit Care Med 2000;28(8): 2758-2765 137 American Academy of Pediatrics Drugs for pediatric emergencies Pediatrics 1998;101(1):E13 138 De Backer D, Vincent JL Norepinephrine administration in septic shock: how much is enough? Crit Care Med 2002;30(6): 1398-1399 139 Siwy BK, Sadove AM Acute management of dopamine infiltration injury with Regitine Plast Reconstr Surg 1987;80(4):610-612 140 McGovern JJ, Cheifetz IM, Craig DM, et al Right ventricular injury in young swine: effects of catecholamines on right ventricular function and pulmonary vascular mechanics Pediatr Res 2000;48(6):763-769 141 Best JD, Halter JB Release and clearance rates of epinephrine in man: importance of arterial measurements J Clin Endocrinol Metab 1982;55(2):263-268 142 Clutter WE, Bier DM, Shah SD, et al Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man J Clin Invest 1980;66(1):94-101 143 Fisher DG, Schwartz PH, Davis AL Pharmacokinetics of exogenous epinephrine in critically ill children Crit Care Med 1993; 21(1):111-117 144 Carcillo JA, Fields AI Clinical practice parameters for hemodynamic support of pediatric and neonatal patients in septic shock Crit Care Med 2002;30(6):1365-1378 145 Colleti J, Brunow de Carvalho W Vasoactive drugs in pediatric shock: in search of a paradigm Pediatr Crit Care Med 2017;18(2): 202-203 e4 146 Meier-Hellmann A, Reinhart K, Bredle DL, et al Epinephrine impairs splanchnic perfusion in septic shock Crit Care Med 1997; 25(3):399-404 147 Day NPJ, Phu NH, Bethell DP, et al The effects of dopamine and adrenaline infusions on acid-base balance and systemic haemodynamics in severe infection Lancet 1996;348(9022):219-223 148 Cheung PY, Barrington KJ, Pearson RJ, et al Systemic, pulmonary and mesenteric perfusion and oxygenation effects of dopamine and epinephrine Am J Respir Crit Care Med 1997;155(1):32-37 149 De Backer D, Creteur J, Silva E, et al Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best? Crit Care Med 2003;31(6):1659-1667 150 Xu Y, Kastner M, Harada L, et al Anaphylaxis-related deaths in Ontario: a retrospective review of cases from 1986 to 2011 Allergy Asthma Clin Immunol 2014;10(1):38 151 Rajah V Treatment of hypotension in very low birthweight infants Arch Dis Child Fetal Neonatal Ed 1998;78(2):F158 152 Michael JR, Guerci AD, Koehler RC, et al Mechanisms by which epinephrine augments cerebral and myocardial perfusion during cardiopulmonary resuscitation in dogs Circulation 1984;69(4): 822-835 153 Zuercher M, Kern KB, Indik JH, et al Epinephrine improves 24hour survival in a swine model of prolonged ventricular fibrillation demonstrating that early intraosseous is superior to delayed intravenous administration Anesth Analg 2011;112(4):884-890 154 Attaran RR, Ewy GA Epinephrine in resuscitation: curse or cure? Future Cardiol 2010;6(4):473-482 155 Olasveengen TM, Sunde K, Brunborg C, et al Intravenous drug administration during out-of-hospital cardiac arrest: a randomized trial JAMA 2009;302(20):2222-2229 156 McEvoy GK, ed Epinephrine In: AHFS Drug Information Bethesda, MD: American Society of Health-System Pharmacists; 2009 157 Brown MJ, Brown DC, Murphy MB Hypokalemia from beta2receptor stimulation by circulating epinephrine N Engl J Med 1983;309(23):1414-1419 158 Levy B Bench-to-bedside review: Is there a place for epinephrine in septic shock? Crit Care 2005;9(6):561-565 159 Solomon SL, Wallace EM, Ford-Jones EL, et al Medication errors with inhalant epinephrine mimicking an epidemic of neonatal sepsis N Engl J Med 1984;310(3):166-170 160 Johnston RR, Eger EI II, Wilson C A comparative interaction of epinephrine with enflurane, isoflurane, and halothane in man Anesth Analg 1976;55(5):709-712 161 Lippmann M, Reisner LS Epinephrine injection with enflurane anaesthesia: incidence of cardiac arrhythmias (author’s transl) Anaesthesist 1975;24(10):437-439 162 Snow JC, Shamsai J, Sakarya I Effects of epinephrine during halothane anesthesia in mastoidotympanoplastic surgery Anesth Analg 1968;47(3):252-256 163 Hayashida N, Tomoeda H, Oda T Inhibitory effect of milrinone on cytokine Ann Thorac Surg 1999;4975(99) 164 Conolly ME, Davies DS, Dollery CT, et al Metabolism of isoprenaline in dog and man Br J Pharmacol 1972;46(3):458-472 165 Conway WD, Minatoya H, Lands a M, et al Absorption and elimination profile of isoproterenol The metabolic fate of dl-isoproterenol-7-3H in the dog J Pharm Sci 1968;57(7):1135-1141 166 Shekerdemian L, Reddington A, Chang AC, et al Cardiovascular Pharmacology Baltimore, MD: Williams & Wilkins; 1998 167 McEvoy GK, ed Isoproterenol hydrochloride In: AHFS Drug Information Bethesda, MD: American Society of Health-System Pharmacists, 2009 168 Ruffolo Jr RR, Spradin TA, Pollock GD, Waddell JE, Murphy PJ Alpha and beta adrenergic effects of the stereoisomers of dobutamine J Pharmacol Exp Ther 1981;219:447-452 169 Al-Hesayen A, Azevedo ER, Newton GE, et al The effects of dobutamine on cardiac sympathetic activity in patients with congestive heart failure J Am Coll Cardiol 2002;39(8):1269-1274 170 Ichai C, Soubielle J, Carles M, et al Comparison of the renal effects of low to high doses of dopamine and dobutamine in critically ill patients: a single-blind randomized study Crit Care Med 2000;28(4):921-928 171 Harada K, Tamura M, Ito T, et al Effects of low-dose dobutamine on left ventricular diastolic filling in children Pediatr Cardiol 1996; 17(4):220-225 172 Cheung PY, Barrington KJ, Bigam D The hemodynamic effects of dobutamine infusion in the chronically instrumented newborn piglet Crit Care Med 1999;27(3):558-564 173 Martinez AM, Padbury JF, Thio S Dobutamine pharmacokinetics and cardiovascular responses in critically ill neonates Pediatrics 1992;89(1):47-51 174 Habib DM, Padbury JF, Anas NG, et al Dobutamine pharmacokinetics and pharmacodynamics in pediatric intensive care patients Crit Care Med 1992;20(5):601-608 175 Berman W, Yabek SM, Dillon T, et al Effects of digoxin in infants with congested circulatory state due to a ventricular septal defect N Engl J Med 1983;308(7):363-366 176 Osborn DA, Paradisis M, Evans N Cochrane Database of Systematic Reviews Chichester, UK: John Wiley & Sons, Ltd; 1996 177 Berré J, De Backer D, Moraine JJ, et al Dobutamine increases cerebral blood flow velocity and jugular bulb hemoglobin saturation in septic patients Crit Care Med 1997;25(3):392-398 178 Habib DM, Padbury JF, Anas NG, et al Dobutamine pharmacokinetics and pharmacodynamics in pediatric intensive care patients Crit Care Med 1992;20(5):601-608 179 Banner Jr W, Vernon DD, Dean JM, Swenson E Nonlinear dopamine pharmacokinetics in pediatric patients J Pharmacol Exp Ther 1989;249:131-133 180 Yan M, Webster LT, Blumer JL 3-O-methyldobutamine, a major metabolite of dobutamine in humans Drug Metab Dispos 2002;30(5):519-524 181 Steinberg C, Notterman DA Pharmacokinetics of cardiovascular drugs in children Inotropes and vasopressors Clin Pharmacokinet 1994;27(5):345-367 182 Mahoney L, Shah G, Crook D, et al A Literature Review of the Pharmacokinetics and Pharmacodynamics of Dobutamine in Neonates Pediatr Cardiol 2016;37(1):14-23 183 Majerus TC, Dasta JF, Bauman JL, et al Dobutamine: ten years later Pharmacotherapy 1989;9(4):245-259 184 Leier CV, Unverferth DV, Kates RE The relationship between plasma dobutamine concentrations and cardiovascular responses in cardiac failure Am J Med 1979;66(2):238-242 185 Berner M, Rouge JC, Friedli B The hemodynamic effect of phentolamine and dobutamine after open-heart operations in children: influence of the underlying heart defect Ann Thorac Surg 1983;35(6):643-650 186 Berner M, Oberhänsli I, Rouge JC, et al Chronotropic and inotropic supports are both required to increase cardiac output early after corrective operations for tetralogy of Fallot J Thorac Cardiovasc Surg 1989;97(2):297-302 187 Cavigelli-Brunner A, Hug MI, Dave H, et al Prevention of low cardiac output syndrome after pediatric cardiac surgery Pediatr Crit Care Med 2018;19(7):619-625 188 Burkhardt B, Rücker G, Stiller B Prophylactic milrinone for the prevention of low cardiac output syndrome and mortality in children undergoing surgery for congenital heart disease (Protocol) Cochrane Libr 2011;(12) 189 Pacold I, Kleinman B, Gunnar R, et al Effects of low-dose dobutamine on coronary hemodynamics, myocardial metabolism, and anginal threshold in patients with coronary artery disease Circulation 1983;68(5):1044-1050 190 Leier CV, Unverferth DV Drugs five years later Dobutamine Ann Intern Med 1983;99(4):490-496 191 Smith RE, Briggs B, Unverferth DU Dobutamine-induced inhibition of platelet function Int J Clin Pharm Res 1982;2:89 192 Robin JK, Oliver JA, Landry DW Vasopressin deficiency in the syndrome of irreversible shock J Trauma 2003;54(suppl 5):S149-S154 e5 193 Landry DW, Oliver JA The pathogenesis of vasodilatory shock N Engl J Med 2001;345(8):588-595 194 Agrawal A, Singh VK, Varma A, et al Therapeutic applications of vasopressin in pediatric patients Indian Pediatr 2012;49(4):297-305 195 Reid IA Role of vasopressin deficiency in the vasodilation of septic shock Circulation 1997;95(5):1108-1110 196 Landry DW, Levin HR, Gallant EM, et al Vasopressin deficiency contributes to the vasodilation of septic shock Circulation 1997;95(5):1122-1125 197 Sharshar T, Blanchard A, Paillard M, et al Circulating vasopressin levels in septic shock Crit Care Med 2003;31(6):1752-1758 198 Morales D, Madigan J, Cullinane S, et al Reversal by vasopressin of intractable hypotension in the late phase of hemorrhagic shock Circulation 1999;100(3):226-229 199 McEvoy GK, ed Vasopressin In: AHFS Drug Information Bethesda, MD: American Society of Health-System Pharmacists; 2009 200 Argent NB, Wilkinson R, Baylis PH Metabolic clearance rate of arginine vasopressin in severe chronic renal failure Clin Sci (Lond) 1992;83(5):583-587 201 Solis-Herruzo JA, Gonzalez-Gamarra A, Castellano G, et al Metabolic clearance rate of arginine vasopressin in patients with cirrhosis Hepatology 1992;16(4):974-979 202 Argenziano M, Choudhri AF, Oz MC, et al A prospective randomized trial of arginine vasopressin in the treatment of vasodilatory shock after left ventricular assist device placement Circulation 1997;96(suppl 9):II-286-II-290 203 Landry DW, Levin HR, Gallant EM, et al Vasopressin pressor hypersensitivity in vasodilatory septic shock Crit Care Med 1997;25(8):1279-1282 204 Rosenzweig EB, Starc TJ, Chen JM, et al Intravenous argininevasopressin in children with vasodilatory shock after cardiac surgery Circulation 1999;100(suppl 19):II182-II186 205 Argenziano M, Chen JM, Choudhri AF, et al Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent J Thorac Cardiovasc Surg 1998;116(6):973-980 206 Dunser MW, Mayr AJ, Ulmer H Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study Circulation 2003;107:2313 207 Dünser M, Mayr A, Stallinger A, et al Cardiac performance during vasopressin infusion in postcardiotomy shock Intensive Care Med 2002;28(6):746-751 208 Holmes CL, Walley KR, Chittock DR, et al The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series Intensive Care Med 2001;27(8):1416-1421 209 Tsuneyoshi I, Yamada H, Kakihana Y, et al Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock Crit Care Med 2001;29(3):487-493 210 Masarwa R, Paret G, Perlman A, et al Role of vasopressin and terlipressin in refractory shock compared to conventional therapy in the neonatal and pediatric population: a systematic review, metaanalysis, and trial sequential analysis Crit Care 2017;21(1):1 211 Liedel JL, Meadow W, Nachman J, et al Use of vasopressin in refractory hypotension in children with vasodilatory shock: five cases and a review of the literature Pediatr Crit Care Med 2002;3(1): 15-18 212 Choong K, Bohn D, Fraser DD, et al Vasopressin in pediatric vasodilatory shock: a multicenter randomized controlled trial Am J Respir Crit Care Med 2009;180(7):632-639 213 Katz K, Lawler J, Wax J, et al Vasopressin presser effects in critically ill children during evaluation for brain death and organ recovery Resuscitation 2000;47:33-40 214 Mann K, Berg RA, Nadkarni V Beneficial effects of vasopressin in prolonged pediatric cardiac arrest: a case series Resuscitation 2002;52:149-156 215 Mendelson J Emergency department management of pediatric shock Emerg Med Clin North Am 2018;36(2):427-440 216 Duncan JM, Meaney P, Simpson P Vasopressin for in-hospital pediatric cardiac arrest: results from the American Heart Association National Registry of Cardiopulmonary Resuscitation Pediatr Crit Care Med 2009;10:191 217 Dünser MW, Mayr AJ, Ulmer H, et al The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: a retrospective analysis Anesth Analg 2001;93(1):7-13 218 Kahn JM, Kress JP, Hall JB Skin necrosis after extravasation of low-dose vasopressin administered for septic shock Crit Care Med 2002;30(8):1899-1901 219 LeJemtel TH, Serrano C Vasopressin dysregulation: hyponatremia, fluid retention and congestive heart failure Int J Cardiol 2007;120(1): 1-9 220 Mohamed A, Nasef N, Shah V, et al Vasopressin as a rescue therapy for refractory pulmonary hypertension in neonates: case series Pediatr Crit Care Med 2014;15(2):148-154 221 Lawless S, Burckart G, Diven W, et al Amrinone in neonates and infants after cardiac surgery Crit Care Med 1989;17(8):751-754 222 Ross MP, Allen-Webb EM, Pappas JB, et al Amrinone-associated thrombocytopenia: pharmacokinetic analysis Clin Pharmacol Ther 1993;53(6):661-667 223 Lebovitz DJ, Lawless ST, Weise KL Fatal amrinone overdose in a pediatric patient Crit Care Med 1995;23(5):977-980 224 Chatterjee K Phosphodiesterase inhibitors: alterations in systemic and coronary hemodynamics Basic Res Cardiol 1989;213(suppl 1): 849 225 Bottorff MB, Rutledge DR, Pieper JA Evaluation of intravenous amrinone: the first of a new class of positive inotropic agents with vasodilator properties Pharmacotherapy 1985;5(5):227-237 226 De Hert SG, Moens MM, Jorens PG, et al Comparison of two different loading doses of milrinone for weaning from cardiopulmonary bypass J Cardiothorac Vasc Anesth 1995;9(3):264-271 227 Levy JH, Bailey JM, Deeb GM Intravenous milrinone in cardiac surgery Ann Thorac Surg 2002;73(1):325-330 228 Karlsberg RP, DeWood MA, DeMaria AN, et al Comparative efficacy of short-term intravenous infusions of milrinone and dobutamine in acute congestive heart failure following acute myocardial infarction Milrinone-Dobutamine Study Group Clin Cardiol 1996; 19(1):21-30 229 Baim DS Effect of phosphodiesterase inhibition on myocardial oxygen consumption and coronary blood flow Am J Cardiol 1989;63(2):23A-26A 230 Nuñez S, Maisel A Comparison between mixed venous oxygen saturation and thermodilution cardiac output in monitoring patients with severe heart failure treated with milrinone and dobutamine Am Heart J 1998;135(3):383-388 231 Wilsmhurst PT, Webb-Peploe MM Side effects of amrinone therapy Br Heart J 1983;49(5):447-451 232 Mammel MC, Einzig S, Kulik TJ, et al Pulmonary vascular effects of amrinone in conscious lambs Pediatr Res 1983;17(9): 720-724 233 Sorensen GK, Ramamoorthy C, Lynn AM, et al Hemodynamic effects of amrinone in children after Fontan surgery Anesth Analg 1996;82(2):241-246 234 Möllhoff T, Loick HM, Van Aken H, et al Milrinone modulates endotoxemia, systemic inflammation, and subsequent acute phase response after cardiopulmonary bypass (CPB) Anesthesiology 1999;90(1):72-80 235 Chang AC, Atz AM, Wernovsky G, et al Milrinone: systemic and pulmonary hemodynamic effects in neonates after cardiac surgery Crit Care Med 1995;23(11):1907-1914 236 Hoffman TM, Wernovsky G, Atz AM, et al Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease Circulation 2003;107(7):996-1002 237 Barton P, Garcia J, Kouatli A, et al Hemodynamic effects of i.v milrinone lactate in pediatric patients with septic shock A prospec- ... chronically instrumented newborn piglet Crit Care Med 1999;27(3):558-564 173 Martinez AM, Padbury JF, Thio S Dobutamine pharmacokinetics and cardiovascular responses in critically ill neonates Pediatrics